Pathogenicity and immunogenicity of live attenuated SIV
Pathogenicity and immunogenicity of live attenuated SIV
批准号:
6559234
负责人:
BARBARA K FELBER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Live-attenuated SIV strains provide an important model to study cellular and viral determinants that contribute to disease development and they also provide a unique tool to study mechanisms leading to protective immunity. We focused our work on the viral Rev protein, a key regulatory factor, which is conserved among lentiviruses and is essential for promoting the export of the unspliced and intermediate-spliced mRNAs which encode the structural proteins. We postulated that a drastic change in the posttranscriptional regulation may affect the pathogenicity of HIV and SIV. To test this hypothesis, we found that the Rev-RRE regulation could be replaced by the posttranscriptional control mechanisms of the simian type D retroviruses. SRV expression is mediated via the cellular NXF1 (formerly called TAP) protein, which interacts with the viral RNA transport element CTE. Our demonstration that CTE could replace Rev/RRE in HIV and SIV resulting in production of infectious virus in PBMC opened the way for the evaluation of the pathogenicity of Rev-independent viruses in the presence of all other viral proteins using animal models. Studies from my lab have now demonstrated that changes of the posttranscriptional regulation of HIV and SIV profoundly alters the out-come of the infection. We have evidence from infection of neonatal, juvenile, and adult rhesus macaques that Rev-independent SIV strains lack pathogenicity (von Gegerfelt, A. S., et al. J Virol. 73:6159-6165, 1999; von Gegerfelt, A. S.et al. J Virol: in press 2001). Our data demonstrate that Rev/RRE regulatory mechanism is required for high levels of virus propagation and that this control mechanism plays an important role in the pathogenicity of SIV. The replacement of Rev/RRE by the NXF1/CTE system provides a novel approach to lower the virulence of a pathogenic lentivirus. The availability of non-pathogenic live-attenuated SIV strains provides us with a unique research tool to dissect pathogenic mechanisms leading to AIDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PATHOGENICITY OF SIVMAC239 VARIANTS IN NEONATAL MACAQUES
-
批准号:7958994
-
项目类别:
-
资助金额:$10.99万
-
财政年份:2009
-
负责人:BARBARA K FELBER
-
依托单位:
PATHOGENICITY OF SIVMAC239 VARIANTS IN NEONATAL MACAQUES
-
批准号:7715569
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2008
-
负责人:BARBARA K FELBER
-
依托单位:
PATHOGENICITY OF SIVMAC239 VARIANTS IN NEONATAL MACAQUES
-
批准号:7562160
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2007
-
负责人:BARBARA K FELBER
-
依托单位:
PATHOGENICITY OF SIVMAC239 VARIANTS IN NEONATAL MACAQUES
-
批准号:7349647
-
项目类别:
-
资助金额:$15.67万
-
财政年份:2006
-
负责人:BARBARA K FELBER
-
依托单位:
PATHOGENICITY OF SIVMAC239 VARIANTS IN NEONATAL MACAQUES
-
批准号:7165446
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2005
-
负责人:BARBARA K FELBER
-
依托单位:
PATHOGENICITY OF SIVMAC239 VARIANTS IN NEONATAL MACAQUES
-
批准号:6971437
-
项目类别:
-
资助金额:$12.23万
-
财政年份:2004
-
负责人:BARBARA K FELBER
-
依托单位:
PATHOGENICITY OF REV INDEPENDENT SIVMAC239 VARIANTS IN NEONATAL MACAQUES
-
批准号:6940445
-
项目类别:
-
资助金额:$16.52万
-
财政年份:2003
-
负责人:BARBARA K FELBER
-
依托单位:
Prevention of AIDS
-
批准号:7338497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Pathogenicity and immunogenicity of live attenuated SIV
-
批准号:7052679
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Prevention of AIDS
-
批准号:8763086
-
项目类别:
-
资助金额:$216.86万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Posttranscriptional control of gene expression
-
批准号:8937714
-
项目类别:
-
资助金额:$51.33万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Immunotherapeutic Interventions of AIDS and Cancer
-
批准号:9556267
-
项目类别:
-
资助金额:$106.25万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Posttranscriptional control of gene expression
-
批准号:7733004
-
项目类别:
-
资助金额:$103.6万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Prevention of AIDS
-
批准号:7733015
-
项目类别:
-
资助金额:$241.74万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Posttranscriptional control of gene expression
-
批准号:6763555
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Conserved Element DNA Vaccine
-
批准号:10014353
-
项目类别:
-
资助金额:$225.17万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Prevention of AIDS
-
批准号:7592681
-
项目类别:
-
资助金额:$76.81万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
COVID-19 vaccine development research
-
批准号:10262556
-
项目类别:
-
资助金额:$93.35万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Prevention of AIDS
-
批准号:10262077
-
项目类别:
-
资助金额:$186.69万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
Posttranscriptional control of gene expression
-
批准号:7291715
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:BARBARA K FELBER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于多组学技术研究肠道微生物在猕猴(Macaca mulatta)衰老过程中的作用机制
-
批准号:32370450
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:范振鑫
-
依托单位:
太行山猕猴(Macaca mulatta tcheliensis)雌性的配偶选择
-
批准号:32070446
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:路纪琪
-
依托单位:
猕猴(Macaca mulatta)衰老过程中凝血功能变化规律及基因表达调控机制研究
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2020
-
负责人:范振鑫
-
依托单位:
猕猴(Macaca mulatta)衰老过程中凝血功能变化规律及基因表达调控机制研究
-
批准号:32070413
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:范振鑫
-
依托单位:
太行山猕猴(Macaca mulatta tcheliensis)雌性的配偶选择
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2020
-
负责人:路纪琪
-
依托单位:
猕猴(Macaca mulatta)亚种及其近缘种比较基因组学研究
-
批准号:31471989
-
项目类别:面上项目
-
资助金额:85.0万元
-
批准年份:2014
-
负责人:刘志瑾
-
依托单位: